Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
PHASE2
The main objective is to evaluate progression-free survival (PFS) at 4 mont...
A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
PHASE2
This is a prospective randomized controlled Phase Ⅱ/Ⅲ Clinical study to eva...
Status
Not Yet Recruiting
Location
Medical Oncology,Sun Yat-sen University Cancer Center
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
N/A
The purpose of this study is to investigate biomarkers which may be predict...